Patents-Review.com
🔗 Permalink
Assignee profile:

DOMPÉ FARMACEUTICI S.P.A.

City:

Milan

Country:

Italy

Published Applications:

19

Last publication date:

2024-08-01

Patent Grants:

19

Last grant date:

2025-12-09

Top Inventors for applications by DOMPÉ FARMACEUTICI S.P.A.

These are the the leading inventors for applications assigned to DOMPÉ FARMACEUTICI S.P.A.:

Recent patent applications by DOMPÉ FARMACEUTICI S.P.A.

DOMPÉ FARMACEUTICI S.P.A. based in Milan, IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-08-01 ✅ Patent 12,491,133 granted on 2025-12-09
US20240252396A1
Human necessities

DEFORMABLE CONTAINER, KIT AND PACKAGING

 #2 | 2023-11-09 ✅ Patent 12,365,644 granted on 2025-07-22
US20230357121A1
Chemistry; metallurgy

CO-CRYSTAL OF KETOPROFEN, LYSINE AND GABAPENTIN, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE

 #3 | 2023-06-15 ✅ Patent 12,582,624 granted on 2026-03-24
US20230181507A1
Human necessities

CO-CRYSTAL OF GABAPENTIN, KETOPROFEN AND LYSINE, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE

 #4 | 2023-01-05 ✅ Patent 12,528,760 granted on 2026-01-20
US20230002302A1
Chemistry; metallurgy

CO-CRYSTAL OF KETOPROFEN AND ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND USES THEREOF

 #5 | 2022-09-22 ✅ Patent 12,186,359 granted on 2025-01-07
US20220296670A1
Human necessities

Composition containing branched-chain amino acids

 #6 | 2022-09-22 ✅ Patent 12,521,359 granted on 2026-01-13
US20220296551A1
Human necessities

COMPOSITION FOR THE TREATMENT OF MUSCLE WASTING

 #7 | 2022-03-10 ✅ Patent 12,285,396 granted on 2025-04-29
US20220071936A1
Human necessities

Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof

 #8 | 2022-02-10 ✅ Patent 11,969,501 granted on 2024-04-30
US20220040095A1
Human necessities

Auris formulations for treating otic diseases and conditions

 #9 | 2021-05-13 ✅ Patent 11,918,653 granted on 2024-03-05
US20210138069A1
Human necessities

Triglyceride otic formulations and uses thereof

 #10 | 2020-04-02 ✅ Patent 12,133,843 granted on 2024-11-05
US20200101046A1
Human necessities

IL-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections

 #11 | 2019-06-06 ✅ Patent 10,508,090 granted on 2019-12-17
US20190169142A1
Chemistry; metallurgy

Sulfonamides as GPR40- and GPR120-agonists

 #12 | 2019-04-11 ✅ Patent 11,046,662 granted on 2021-06-29
US20190106395A1
Chemistry; metallurgy

2-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthma

 #13 | 2019-01-17 ✅ Patent 12,268,671 granted on 2025-04-08
US20190015391A1
Human necessities

IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy

 #14 | 2018-11-08 ✅ Patent 10,246,448 granted on 2019-04-02
US20180319785A1
Chemistry; metallurgy

4-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as TRPM8 antagonists

 #15 | 2018-07-19 ✅ Patent 12,150,933 granted on 2024-11-26
US20180200231A1
Human necessities

IL-8 inihibitors for use in the treatment of some urological disorders

 #16 | 2017-07-06 ✅ Patent 10,196,368 granted on 2019-02-05
US20170190678A1
Chemistry; metallurgy

2-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthma

 #17 | 2014-12-18 ✅ Patent 9,585,875 granted on 2017-03-07
US20140371276A1
Chemistry; metallurgy

TRPM8 antagonists

 #18 | 2013-03-28 ✅ Patent 9,493,402 granted on 2016-11-15
US20130079514A1
Chemistry; metallurgy

Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells

 #19 | 2012-06-07 ✅ Patent 9,345,749 granted on 2016-05-24
US20120142591A1
Human necessities

Method of treating intraoccular tissue pathologies with nerve growth factor

Also check out DOMPÉ FARMACEUTICI S.P.A.'s (Milan, Italy) applicant profile with 16 patent applications submitted.

AssigneeID:

508029 ⎘